UPSC MainsANI-HUSB-VETER-SCIENCE-PAPER-II202020 Marks
हिंदी में पढ़ें
Q12.

Write a detailed note on types of immunity. Differentiate between attenuated and inactivated vaccines.

How to Approach

This question requires a structured response outlining the types of immunity – innate, adaptive, and passive – followed by a detailed comparison of attenuated and inactivated vaccines. The answer should begin by defining immunity and its importance. The body should then elaborate on each type of immunity, explaining the mechanisms involved. The vaccine comparison should highlight the advantages, disadvantages, and safety considerations of each type. A concluding summary reinforcing key differences is vital.

Model Answer

0 min read

Introduction

Immunity, the body's ability to resist disease, is a cornerstone of public health. The COVID-19 pandemic underscored the critical role of immune responses in combating infectious diseases and the importance of vaccination strategies. Understanding the different types of immunity and the mechanisms behind vaccine development is crucial for effective disease prevention and control. This note will explore the various forms of immunity, detailing both innate and adaptive responses, and will then differentiate between attenuated and inactivated vaccines, two common types of immunization.

Types of Immunity

Immunity can be broadly classified into innate and adaptive immunity. Passive immunity is also a significant category.

1. Innate Immunity

Innate immunity is the first line of defense against pathogens. It’s non-specific and present from birth. It includes physical barriers (skin, mucous membranes), chemical barriers (enzymes, acids), and cellular defenses (macrophages, neutrophils, natural killer cells). It's a rapid response, but lacks immunological memory.

  • Physical Barriers: Skin, mucous membranes, cilia
  • Chemical Barriers: Lysozyme in tears and saliva, stomach acid
  • Cellular Defenses: Phagocytes (macrophages, neutrophils), Natural Killer (NK) cells

2. Adaptive Immunity

Adaptive immunity is a specific and acquired response that develops after exposure to a pathogen. It involves lymphocytes (B cells and T cells) and creates immunological memory, providing long-lasting protection. It's slower to develop than innate immunity but is highly targeted.

  • Humoral Immunity: Mediated by B cells, which produce antibodies. Antibodies neutralize pathogens and mark them for destruction.
  • Cell-mediated Immunity: Mediated by T cells. Cytotoxic T cells (CD8+) directly kill infected cells. Helper T cells (CD4+) assist B cells and cytotoxic T cells.

3. Passive Immunity

Passive immunity is acquired through the transfer of antibodies from one individual to another. It provides immediate but temporary protection. Examples include antibodies passed from mother to fetus (transplacental immunity) and through breast milk (colostrum).

  • Transplacental Immunity: Antibodies passed from mother to fetus.
  • Colostrum: Antibodies passed through breast milk.
  • Antibody Injections: Temporary protection from diseases like rabies or tetanus.

Attenuated vs. Inactivated Vaccines

Vaccines are designed to stimulate the adaptive immune system without causing the disease. They utilize either attenuated (weakened) or inactivated (killed) pathogens.

Attenuated Vaccines

Attenuated vaccines contain a weakened version of the live pathogen. The pathogen is modified through repeated passage in cell culture or through genetic manipulation to reduce its virulence. They elicit a strong and long-lasting immune response, often mimicking natural infection. However, they pose a risk of reversion to virulence and are generally contraindicated in immunocompromised individuals.

  • Mechanism: Stimulates both humoral and cell-mediated immunity.
  • Advantages: Strong and long-lasting immunity, often requires fewer doses.
  • Disadvantages: Risk of reversion to virulence, not suitable for immunocompromised individuals, requires careful storage (cold chain).
  • Examples: Measles, Mumps, Rubella (MMR) vaccine, Varicella (chickenpox) vaccine, Oral Polio Vaccine (OPV - phased out in many countries due to reversion risk).

Inactivated Vaccines

Inactivated vaccines contain killed pathogens. These pathogens are rendered incapable of replicating but retain their antigens, which stimulate an immune response. They are generally safer than attenuated vaccines but may elicit a weaker immune response, requiring multiple doses and booster shots. They do not carry the risk of reversion to virulence.

  • Mechanism: Primarily stimulates humoral immunity.
  • Advantages: Safe for immunocompromised individuals, no risk of reversion to virulence.
  • Disadvantages: Weaker immune response, requires multiple doses and boosters, less effective than attenuated vaccines.
  • Examples: Inactivated Polio Vaccine (IPV), Hepatitis A vaccine, Influenza vaccine (injected form), Rabies vaccine.
Feature Attenuated Vaccines Inactivated Vaccines
Pathogen Status Weakened live pathogen Killed pathogen
Immune Response Strong, long-lasting, cellular & humoral Weaker, primarily humoral
Risk of Reversion Yes No
Safety for Immunocompromised Generally contraindicated Safe
Dose Requirements Fewer doses Multiple doses & boosters

The National Immunization Schedule (NIS) in India utilizes both types of vaccines, strategically combining them to provide optimal protection against various diseases. The Universal Immunization Programme (UIP) is a key initiative under the National Health Mission.

Conclusion

In conclusion, immunity encompasses a spectrum of defenses, from the immediate innate response to the acquired adaptive immunity. Understanding the nuances of attenuated and inactivated vaccines is crucial for informed decision-making in public health. While attenuated vaccines offer a robust immune response, their potential risks necessitate careful consideration. Inactivated vaccines provide a safer alternative, albeit with a potentially weaker response requiring boosters. Continued research and development are essential for creating more effective and safer vaccines to combat emerging infectious diseases.

Answer Length

This is a comprehensive model answer for learning purposes and may exceed the word limit. In the exam, always adhere to the prescribed word count.

Additional Resources

Key Definitions

Immunological Memory
The ability of the adaptive immune system to "remember" previous encounters with pathogens, allowing for a faster and more effective response upon re-exposure.
Antigen
A substance that triggers an immune response, typically a protein or polysaccharide found on the surface of pathogens.

Key Statistics

Globally, an estimated 2.5 million children die each year from vaccine-preventable diseases. (WHO, 2021)

Source: World Health Organization

The measles vaccination coverage rate globally fell from 93% in 2000 to 84% in 2019, increasing the risk of outbreaks. (UNICEF, 2020)

Source: UNICEF

Examples

COVID-19 Vaccines

mRNA vaccines (e.g., Pfizer-BioNTech, Moderna) represent a newer generation of vaccines that stimulate the body to produce viral proteins, triggering an immune response. These are neither attenuated nor inactivated.

Yellow Fever Vaccine

The Yellow Fever vaccine is an attenuated live virus vaccine, highlighting the effectiveness of this approach for certain diseases, despite the associated risks.

Frequently Asked Questions

Can a person with a weakened immune system receive live attenuated vaccines?

Generally, no. Live attenuated vaccines are typically contraindicated in individuals with compromised immune systems due to the risk of developing the disease.

Topics Covered

Veterinary ImmunologyVaccinationImmune SystemVaccine TypesImmunology